On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.

On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.